Concepedia
Statistics
Publications
20
Citations
1.1K
H-Index
17
Active since
1993
Affiliations
Novartis (United States)(Current)
University of Nottingham
University of Illinois Urbana-Champaign
University of Bath
Genomics Institute of the Novartis Research Foundation
Paul A. Barsanti is an author at Novartis (United States) specializing in natural sciences, organic chemistry, and biochemistry.
Top concepts
Natural SciencesBiochemistryOrganic ChemistryMedicineChemistryDrug DiscoveryPharmacologyEngineeringMedicinal ChemistryPharmacotherapy
Publications per year
1993–2019
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
K.R. Simonetta, Joshua P. Taygerly, Kathleen Boyle et al. · Nature Communications · 2019 · 196 citations · Full text
Enantioselective Ring Opening of Epoxides with Silicon Tetrachloride in the Presence of a Chiral Lewis Base
Scott E. Denmark, Paul A. Barsanti, Ken‐Tsung Wong et al. · The Journal of Organic Chemistry · 1998 · 176 citations
Chemical Engineering, Engineering, Silicon Tetrachloride +11
A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function
Daniel L. Menezes, Jenny Holt, Yan Tang et al. · Molecular Cancer Research · 2014 · 99 citations
The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5
Paul A. Barsanti, Weibo Wang, Zhi‐Jie Ni et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 98 citations · Full text
Biochemistry, Medicine, Natural Sciences +8
4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors
Zhi‐Jie Ni, Paul A. Barsanti, Nathan Brammeier et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 70 citations · Full text
Medicinal Chemistry, Potent Chk-1 Inhibitors, Medicine +6
1–5 of 20